A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
Alliance for Regenerative Medicine Releases Q3 2015 Data Report, Highlighting Sector Trends and Metrics
WASHINGTON, D.C., November 2, 2015 – The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, today announced the release of its...
Trends for Microanalytical Systems and Chip-based Bioanalysis - Focus: real time PCR
Alacris Theranostics enters agreement with GSK to use ModCellTM System for early stage cancer research
Alacris Theranostics has entered into an agreement with GlaxoSmithKline (GSK) to apply Alacris' proprietary ModCellTM System, developed at the Max Planck Institute for Molecular Genetics and licensed exclusively to Alacris, for...
Entrance Markgrafenstraße 38
The German Conference on Bioinformatics (GCB) is an annual, international conference devoted to all areas of bioinformatics. Recent meetings attracted a multinational audience with 250 – 300 participants each year. The meeting is...
Nils Ericsons Plan 4
The largest Nordic partnering conference for the global Life Science industry / HealthCapital Berlin-Brandenburg is acting as conference supporter / Early Bird rates apply!